GLP 1
Pharmacy GLP-1 Tracker: Where Each Drug Is Available
In 2026, no single GLP-1 medication is in formal FDA shortage, but most still have soft spots somewhere in the supply chain.
Pharmacogenomics: Why GLP-1 Works Better for Some People
Response to GLP-1 medications varies widely.
Persistent Nausea on GLP-1: When It Won’t Stop
Some nausea in the first 4 to 8 weeks of a GLP-1 is expected. The drug slows gastric emptying, and the body needs time to adjust.
Pen vs Vial: Which GLP-1 Format Is Right for You
The choice between prefilled pen and multi-dose vial is mostly about convenience, cost, and dosing flexibility.
Pen Injector vs Vial & Syringe: Which GLP-1 Delivery System?
GLP-1 medications come in two main delivery formats.
Pemvidutide Switching to or From: Transition Protocols & Dose Conversion
Pemvidutide isn’t FDA-approved yet, so switching protocols are theoretical and based on what’s standard for GLP-1 class transitions.
Pemvidutide Storage, Travel & Handling: Everything You Need to Know
Introduction Pemvidutide is an investigational peptide, similar in physical properties to semaglutide and tirzepatide, with the same storage and handling considerations that apply to…
Pemvidutide Side Effects: Complete Profile, Management & When to Call Your Doctor
Introduction Pemvidutide’s side effect profile from phase 2 trials looks roughly similar to other GLP-1-based weight loss drugs, with the dominant complaints being gastrointestinal…
Pemvidutide Latest Research: New Indications, Trials & What’s Coming
Pemvidutide had a strong 2024 research year.
